How Does Dysregulated Translation Contribute to Cancer?
Dysregulated translation in cancer can result from mutations in genes encoding translation factors, alterations in signaling pathways like PI3K/AKT/mTOR, or changes in the expression of miRNAs that regulate mRNA translation. These alterations can lead to increased synthesis of oncogenic proteins or decreased synthesis of tumor suppressor proteins, thereby driving cancer progression.
